Alessandra de Paula Carli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alessandra de Paula Carli has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Caio César Souza Alves
Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil
14 shared publications - Sandra Bertelli Ribeiro Castro
Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil
10 shared publications - Nerilson Marques Lima
Universidade Federal de Alfenas
6 shared publications - Gabriela de Paula Carli
Universidade Federal de Juiz de Fora
4 shared publications - Gracimério José Guarneire
Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil
3 shared publications - Diego Mendes Xavier
Department of Physiotherapy, Universidade Federal dos Vales do Jequitinhonha e Mucuri
2 shared publications
Latest Publications
- Open Access
- 10 August 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 182
Combination of Bauhinia monandra extract and laser acupuncture reduces carrageenan-induced paw edema
Purpose: To investigate the anti-inflammatory effect of the ethanolic extract of Bauhinia monandra Kurz (EEB) alone and combined with laser acupuncture (LA) in a carrageenan-induced paw edema model. Methods: EEB was characterized using HPLC–HRMS and tested for cell viability and nitric oxide (NO) production in RAW 264.7 and J774A.1 macrophages. In vivo, female BALB/c mice with paw edema were treated with EEB (100 or 200 mg/kg) alone, combined with LA (808 nm, 120 mW, 3 J, 25 s) at acupoints ST36 and SP6, or local laser. Paw edema was measured up to 4 h post-induction, and cytokine levels (IL-1$\beta$ and IL-6) were quantified. Results: EEB showed no cytotoxicity and significantly reduced NO production in vitro. Phytochemical analysis revealed a predominance of phenolic compounds, including flavonoids. In vivo, both EEB and LA significantly reduced edema. Notably, the EEB200 + LA group produced reductions in paw edema and pro-inflammatory cytokines comparable to the dexamethasone group. Conclusion: EEB demonstrated anti-inflammatory activity both in vitro and in vivo. Combining EEB (200 mg/kg) with LA yielded a more consistent anti-inflammatory response than either treatment alone, particularly in reducing edema and pro-inflammatory cytokines. These findings support further investigation, though larger sample sizes and chronic models are required before clinical claims.
- 10 August 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 182
Open AccessCombination of Bauhinia monandra extract and laser acupuncture reduces carrageenan-induced paw edema
Purpose: To investigate the anti-inflammatory effect of the ethanolic extract of Bauhinia monandra Kurz (EEB) alone and combined with laser acupuncture (LA) in a carrageenan-induced paw edema model. Methods: EEB was characterized using HPLC–HRMS and tested for cell viability and nitric oxide (NO) production in RAW 264.7 and J774A.1 macrophages. In vivo, female BALB/c mice with paw edema were treated with EEB (100 or 200 mg/kg) alone, combined with LA (808 nm, 120 mW, 3 J, 25 s) at acupoints ST36 and SP6, or local laser. Paw edema was measured up to 4 h post-induction, and cytokine levels (IL-1$\beta$ and IL-6) were quantified. Results: EEB showed no cytotoxicity and significantly reduced NO production in vitro. Phytochemical analysis revealed a predominance of phenolic compounds, including flavonoids. In vivo, both EEB and LA significantly reduced edema. Notably, the EEB200 + LA group produced reductions in paw edema and pro-inflammatory cytokines comparable to the dexamethasone group. Conclusion: EEB demonstrated anti-inflammatory activity both in vitro and in vivo. Combining EEB (200 mg/kg) with LA yielded a more consistent anti-inflammatory response than either treatment alone, particularly in reducing edema and pro-inflammatory cytokines. These findings support further investigation, though larger sample sizes and chronic models are required before clinical claims.
- Open Access
- 30 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 6854
High-Intensity Interval Training Snacks Improve Experimental Autoimmune Encephalomyelitis
Several studies have shown that physical activity is associated with increased life expectancy and the prevention of chronic and neurodegenerative diseases. This study aimed to evaluate the impact of high-intensity interval training (HIIT) on the progression of an experimental model of multiple sclerosis. For this purpose, the murine model of experimental encephalomyelitis (EAE) was used in female C57BL/6 mice, divided into four groups: negative control (CN), positive control (EAE), HIIT once a day (1-HIIT), and HIIT snacks, three times a day (3-HIIT). The clinical score results demonstrated a significant reduction in the clinical score in mice subjected to 3-HIIT, confirmed by analyses of pro- and anti-inflammatory cytokines and histological analyses. These results provided solid evidence for the potential of HIIT protocols, especially 3-HIIT, to reprogram an autoimmune response in the CNS in mice with the EAE model, favoring a neuroprotective and immunoregulatory environment—evidence that may drive clinical research.
- 30 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 6854
Open AccessHigh-Intensity Interval Training Snacks Improve Experimental Autoimmune Encephalomyelitis
Several studies have shown that physical activity is associated with increased life expectancy and the prevention of chronic and neurodegenerative diseases. This study aimed to evaluate the impact of high-intensity interval training (HIIT) on the progression of an experimental model of multiple sclerosis. For this purpose, the murine model of experimental encephalomyelitis (EAE) was used in female C57BL/6 mice, divided into four groups: negative control (CN), positive control (EAE), HIIT once a day (1-HIIT), and HIIT snacks, three times a day (3-HIIT). The clinical score results demonstrated a significant reduction in the clinical score in mice subjected to 3-HIIT, confirmed by analyses of pro- and anti-inflammatory cytokines and histological analyses. These results provided solid evidence for the potential of HIIT protocols, especially 3-HIIT, to reprogram an autoimmune response in the CNS in mice with the EAE model, favoring a neuroprotective and immunoregulatory environment—evidence that may drive clinical research.
- Open Access
- 21 February 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 35
Synergistic anti-inflammatory effects of the aqueous extract from Desmodium heterophyllum and photobiomodulation in a carrageenan-induced paw edema model
Inflammation is a complex biological response that, when uncontrolled, contributes to the development and worsening of several pathological conditions. Identifying safe and effective anti-inflammatory strategies remains an important therapeutic challenge. In this context, medicinal plants and photobiomodulation therapy (PBM) have emerged as promising approaches due to their immunomodulatory potential. This study aimed to investigate the anti-inflammatory properties of the aqueous extract from Desmodium heterophyllum (AEDh), alone and in combination with PBM, using a carrageenan-induced paw edema model. AEDh was obtained, chemically characterized through high-resolution mass spectrometry, and evaluated for cytotoxicity and nitric oxide (NO) production in J774A.1 and RAW 264.7 macrophages. In vivo anti-inflammatory activity was assessed in BALB/c mice subjected to carrageenan-induced paw edema and treated with AEDh (50–250 mg/kg), PBM (780 nm, 70 mW, 35 J/cm²), or their combination. Paw thickness was measured for up to 4 h post-induction, and cytokine levels (IL-1β, IL-6, TNF, IFN-γ) were quantified by enzyme-linked immunosorbent assay (ELISA). AEDh showed no cytotoxicity at the concentrations tested and significantly reduced NO production in vitro. In vivo, both AEDh and PBM reduced paw edema, with the combined treatment—especially AEDh at 250 mg/kg—producing a more pronounced effect, comparable to dexamethasone. The combination also markedly reduced pro-inflammatory cytokines, particularly IL-1β and IL-6, supporting a synergistic action. AEDh demonstrated relevant anti-inflammatory and immunomodulatory activity, which was further enhanced when combined with PBM. These findings highlight the therapeutic potential of integrating herbal medicine and photobiomodulation as a safe and effective strategy for managing inflammatory conditions. Keywords: Desmodium heterophyllum; Photobiomodulation; Cytokines; Synergistic effect; Low-level laser therapy.
- 21 February 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 35
Open AccessSynergistic anti-inflammatory effects of the aqueous extract from Desmodium heterophyllum and photobiomodulation in a carrageenan-induced paw edema model
Inflammation is a complex biological response that, when uncontrolled, contributes to the development and worsening of several pathological conditions. Identifying safe and effective anti-inflammatory strategies remains an important therapeutic challenge. In this context, medicinal plants and photobiomodulation therapy (PBM) have emerged as promising approaches due to their immunomodulatory potential. This study aimed to investigate the anti-inflammatory properties of the aqueous extract from Desmodium heterophyllum (AEDh), alone and in combination with PBM, using a carrageenan-induced paw edema model. AEDh was obtained, chemically characterized through high-resolution mass spectrometry, and evaluated for cytotoxicity and nitric oxide (NO) production in J774A.1 and RAW 264.7 macrophages. In vivo anti-inflammatory activity was assessed in BALB/c mice subjected to carrageenan-induced paw edema and treated with AEDh (50–250 mg/kg), PBM (780 nm, 70 mW, 35 J/cm²), or their combination. Paw thickness was measured for up to 4 h post-induction, and cytokine levels (IL-1β, IL-6, TNF, IFN-γ) were quantified by enzyme-linked immunosorbent assay (ELISA). AEDh showed no cytotoxicity at the concentrations tested and significantly reduced NO production in vitro. In vivo, both AEDh and PBM reduced paw edema, with the combined treatment—especially AEDh at 250 mg/kg—producing a more pronounced effect, comparable to dexamethasone. The combination also markedly reduced pro-inflammatory cytokines, particularly IL-1β and IL-6, supporting a synergistic action. AEDh demonstrated relevant anti-inflammatory and immunomodulatory activity, which was further enhanced when combined with PBM. These findings highlight the therapeutic potential of integrating herbal medicine and photobiomodulation as a safe and effective strategy for managing inflammatory conditions. Keywords: Desmodium heterophyllum; Photobiomodulation; Cytokines; Synergistic effect; Low-level laser therapy.
- 1 November 2025
- Published by Fiocruz - Instituto de Tecnologia em Farmacos in Revista Fitos
- Vol. 19 (1)
Cytotoxicity assessment and molecular diversity through mass spectrometry analysis of Costus spicatus
- 1 November 2025
- Published by Fiocruz - Instituto de Tecnologia em Farmacos in Revista Fitos
- Vol. 19 (1)
Cytotoxicity assessment and molecular diversity through mass spectrometry analysis of Costus spicatus
- 1 April 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (4) , 1-11
Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation
The immunopathogenesis of multiple sclerosis (MS) involves the activation of T lymphocytes, leading to progressive axonal loss and brain atrophy. Ursolic acid (AU) has been widely used as an herbal medicine, with the ability to inhibit the production and secretion of cytokines and may influence the differentiation of CD4 + helper cells. In this study, we aimed to investigate the immunomodulatory effects of ursolic acid derivatives (methyl 3β-hydroxyurs-12-en-28-oate (AUD1) and methyl 3β-acetoxyurs-12-en-28-oate (AUD2)) in a model of experimental autoimmune encephalomyelitis (EAE). EAE was induced by subcutaneous immunization of myelin oligodendrocyte glycoprotein peptide (MOG35−55) in C57BL/6 mice. On the 15th day post-induction (dpi), the mice were treated with AU, AUD1, or AUD2 (50 mg/kg intraperitoneally per day) for six days. Clinical signs were monitored until 21 dpi, and parameters were assessed in the spinal cord, lymph nodes, and brain at 21 dpi. The results showed that both derivatives similarly attenuated the clinical signs of EAE and reduced inflammation and demyelination in the spinal cord. In addition, they reduced the number of pro-inflammatory cells in the brain, the level of IL-1β, TNF, and IFN-γ in the spinal cord, and, in the periphery, promoted the regulation of pro-inflammatory cells. In conclusion, regulating cells in the periphery and reducing the number of pro-inflammatory cells in the CNS, with AUD1 and AUD2, culminated in the efficacy of the clinical parameters presented in EAE, suggesting a therapeutic potential for treating MS.
- 1 April 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (4) , 1-11
Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation
The immunopathogenesis of multiple sclerosis (MS) involves the activation of T lymphocytes, leading to progressive axonal loss and brain atrophy. Ursolic acid (AU) has been widely used as an herbal medicine, with the ability to inhibit the production and secretion of cytokines and may influence the differentiation of CD4 + helper cells. In this study, we aimed to investigate the immunomodulatory effects of ursolic acid derivatives (methyl 3β-hydroxyurs-12-en-28-oate (AUD1) and methyl 3β-acetoxyurs-12-en-28-oate (AUD2)) in a model of experimental autoimmune encephalomyelitis (EAE). EAE was induced by subcutaneous immunization of myelin oligodendrocyte glycoprotein peptide (MOG35−55) in C57BL/6 mice. On the 15th day post-induction (dpi), the mice were treated with AU, AUD1, or AUD2 (50 mg/kg intraperitoneally per day) for six days. Clinical signs were monitored until 21 dpi, and parameters were assessed in the spinal cord, lymph nodes, and brain at 21 dpi. The results showed that both derivatives similarly attenuated the clinical signs of EAE and reduced inflammation and demyelination in the spinal cord. In addition, they reduced the number of pro-inflammatory cells in the brain, the level of IL-1β, TNF, and IFN-γ in the spinal cord, and, in the periphery, promoted the regulation of pro-inflammatory cells. In conclusion, regulating cells in the periphery and reducing the number of pro-inflammatory cells in the CNS, with AUD1 and AUD2, culminated in the efficacy of the clinical parameters presented in EAE, suggesting a therapeutic potential for treating MS.
- Open Access
- 6 September 2023
- Published by Seven Events
Multiple sclerosis and experimental autoimmune encephalomyelitis: A review
Multiple sclerosis is a chronic inflammatory autoimmune disease of the central nervous system, characterized by mononuclear cell infiltration, axon demyelination and gliosis in the myelin sheath, with formation of multiple plaques. It affects individuals aged between 25 and 50 years old, female and residents of higher latitudes. The etiology of multiple sclerosis is multifactorial and not fully understood; however, the influence of genetic predisposition and environmental factors on immune dysregulation is recognized. The pathophysiology of the disease is mediated by self-reactive T lymphocytes that respond to autoantigens from the central nervous system. The emergence of multifocal regions of demyelination, axonal loss, loss of oligodendrocytes and astroglial scarring result in impaired neurological function, leading to neurodegeneration. Although there is still no cure for multiple sclerosis, scientific research has provided great advances in therapeutic strategies. Currently there are approaches to attenuate specific signs and symptoms, drugs to control disease relapses and treatments designed to modify or delay the course of multiple sclerosis. Although these drugs show promising effects, they are ineffective in curing the patient. In addition, they present a fundamental problem, which is the non-selective action on the cells of the immune system, which triggers serious side effects. Considering the limitations of studies in humans due to the difficulty of accessing the affected tissues, the use of experimental models that simulate the singularities of multiple sclerosis is a key element for the study of the pathogenesis of inflammation and therapeutic alternatives. Experimental autoimmune encephalomyelitis, an animal model that presents several similarities with pathophysiological, histological and clinical aspects of multiple sclerosis, is the most used model for these studies. Therefore, in this chapter, the aim was to review the historical context, definition, etiology, pathophysiology, clinical manifestations, diagnosis and treatment of multiple sclerosis and, at the same time, address aspects of the timeline, induction, the evolutionary course and the immunopathogenesis of the most studied model for the investigation of the nuances of multiple sclerosis, correlating the similarities and differences between both. DOI:https://doi.org/10.56238/uniknowindevolp-045
- 6 September 2023
- Published by Seven Events
Open AccessMultiple sclerosis and experimental autoimmune encephalomyelitis: A review
Multiple sclerosis is a chronic inflammatory autoimmune disease of the central nervous system, characterized by mononuclear cell infiltration, axon demyelination and gliosis in the myelin sheath, with formation of multiple plaques. It affects individuals aged between 25 and 50 years old, female and residents of higher latitudes. The etiology of multiple sclerosis is multifactorial and not fully understood; however, the influence of genetic predisposition and environmental factors on immune dysregulation is recognized. The pathophysiology of the disease is mediated by self-reactive T lymphocytes that respond to autoantigens from the central nervous system. The emergence of multifocal regions of demyelination, axonal loss, loss of oligodendrocytes and astroglial scarring result in impaired neurological function, leading to neurodegeneration. Although there is still no cure for multiple sclerosis, scientific research has provided great advances in therapeutic strategies. Currently there are approaches to attenuate specific signs and symptoms, drugs to control disease relapses and treatments designed to modify or delay the course of multiple sclerosis. Although these drugs show promising effects, they are ineffective in curing the patient. In addition, they present a fundamental problem, which is the non-selective action on the cells of the immune system, which triggers serious side effects. Considering the limitations of studies in humans due to the difficulty of accessing the affected tissues, the use of experimental models that simulate the singularities of multiple sclerosis is a key element for the study of the pathogenesis of inflammation and therapeutic alternatives. Experimental autoimmune encephalomyelitis, an animal model that presents several similarities with pathophysiological, histological and clinical aspects of multiple sclerosis, is the most used model for these studies. Therefore, in this chapter, the aim was to review the historical context, definition, etiology, pathophysiology, clinical manifestations, diagnosis and treatment of multiple sclerosis and, at the same time, address aspects of the timeline, induction, the evolutionary course and the immunopathogenesis of the most studied model for the investigation of the nuances of multiple sclerosis, correlating the similarities and differences between both. DOI:https://doi.org/10.56238/uniknowindevolp-045
- Open Access
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Impactos da suplementação nutricional com cúrcuma sobre testes de funções executivas em universitários
Introduction: Executive functions (EFs) involve three interconnected dimensions: working memory, cognitive flexibility and inhibitory control. Curcumin, present in Curcuma longa rhizomes or turmeric, has been used for its anti-inflammatory, antioxidant, anticancer, and neuroprotective effects, with potential for prevention/treatment of highly prevalent pathologies that burden healthcare systems, such as dementias. Methodology: This paper evaluated whether turmeric consumption by college students impacts their executive performance. University students underwent tests assessing FEs before and after nutritional supplementation with 1g/day of turmeric for 4 weeks. Results: Acute or chronic turmeric consumption had no significant impacts on tests assessing selective attention, working memory, abstract reasoning, cognitive strategy modification and problem solving. Conclusions: The absence of significant effects may be due to the characteristics of the experimental design that analyzed a young population with cognitive integrity. The low absorption/bioavailability of curcumin may also have influenced the results.
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Open AccessImpactos da suplementação nutricional com cúrcuma sobre testes de funções executivas em universitários
Introduction: Executive functions (EFs) involve three interconnected dimensions: working memory, cognitive flexibility and inhibitory control. Curcumin, present in Curcuma longa rhizomes or turmeric, has been used for its anti-inflammatory, antioxidant, anticancer, and neuroprotective effects, with potential for prevention/treatment of highly prevalent pathologies that burden healthcare systems, such as dementias. Methodology: This paper evaluated whether turmeric consumption by college students impacts their executive performance. University students underwent tests assessing FEs before and after nutritional supplementation with 1g/day of turmeric for 4 weeks. Results: Acute or chronic turmeric consumption had no significant impacts on tests assessing selective attention, working memory, abstract reasoning, cognitive strategy modification and problem solving. Conclusions: The absence of significant effects may be due to the characteristics of the experimental design that analyzed a young population with cognitive integrity. The low absorption/bioavailability of curcumin may also have influenced the results.
- Open Access
- 21 July 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (10)
Leishmania infection in seropositive dogs in the Mucuri Valley Region, Minas Gerais, Brazil
Introduction: Canine Visceral Leishmaniasis (CVL) is a severe systemic zoonosis that has the dog as the main reservoir for human disease. As it is a neglected tropical disease, there are gaps in its aspects, especially in regional terms. In this sense, the aim was to evaluate the profile of infected animals and identify the prevalent species in canine infection in the macro-region of Mucuri Valley, Minas Gerais, Brazil, through the polymerase chain reaction (PCR-RFLP-ITS1). Methodology: Cross-sectional observational study carried out between August/2019 and February/2020 at the San Francisco Veterinary Clinic and the Municipal Dog Kennel. Positive animals to the DPP® were selected and biological samples were collected: venous blood (SNAP); ear skin fragment (imprint); and bone marrow aspirate to smear slides, isolation in culture environment, and molecular diagnosis. All animals underwent clinical examination and data collection: provenance, symptoms, fur, age, sex. Results: In 88 of the 132 samples, the presence of Leishmania’s DNA was detected and in 87.3% the species L. infantum was identified. Of these 88 animals, 69 had symptoms; 45 were males; 73 with short fur. The highest frequency of positive PCR occurred between 2-5 years (55 animals). 91.67% were SNAP test positive. Conclusions: The present study made it possible to understand aspects of CVL in the evaluated samples and to identify the etiological agent most prevalent in the area, allowing the establishment of efficient strategies to control the disease in dogs and to prevent human infection in the region.
- 21 July 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (10)
Open AccessLeishmania infection in seropositive dogs in the Mucuri Valley Region, Minas Gerais, Brazil
Introduction: Canine Visceral Leishmaniasis (CVL) is a severe systemic zoonosis that has the dog as the main reservoir for human disease. As it is a neglected tropical disease, there are gaps in its aspects, especially in regional terms. In this sense, the aim was to evaluate the profile of infected animals and identify the prevalent species in canine infection in the macro-region of Mucuri Valley, Minas Gerais, Brazil, through the polymerase chain reaction (PCR-RFLP-ITS1). Methodology: Cross-sectional observational study carried out between August/2019 and February/2020 at the San Francisco Veterinary Clinic and the Municipal Dog Kennel. Positive animals to the DPP® were selected and biological samples were collected: venous blood (SNAP); ear skin fragment (imprint); and bone marrow aspirate to smear slides, isolation in culture environment, and molecular diagnosis. All animals underwent clinical examination and data collection: provenance, symptoms, fur, age, sex. Results: In 88 of the 132 samples, the presence of Leishmania’s DNA was detected and in 87.3% the species L. infantum was identified. Of these 88 animals, 69 had symptoms; 45 were males; 73 with short fur. The highest frequency of positive PCR occurred between 2-5 years (55 animals). 91.67% were SNAP test positive. Conclusions: The present study made it possible to understand aspects of CVL in the evaluated samples and to identify the etiological agent most prevalent in the area, allowing the establishment of efficient strategies to control the disease in dogs and to prevent human infection in the region.
- Open Access
- 23 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (14)
Leishmaniose Tegumentar Americana: uma análise epidemiológica do município de Teófilo Otoni-MG
Em gradual processo de urbanização, a Leishmaniose Tegumentar Americana (LTA) é uma antropozoonose preocupante em decorrência da sua gravidade e ameaça à saúde pública. O presente trabalho teve como objetivo avaliar a incidência de casos de LTA no período de 2014 a 2018 e traçar um perfil epidemiológico da enfermidade no município de Teófilo Otoni – MG a partir dos dados: sexo, faixa-etária, raça, forma de entrada no sistema, área de moradia e bairro, formas clínicas apresentadas, método diagnóstico e medicações utilizadas no tratamento. Foram notificados 75 casos no período, sendo a população parda, masculina e de faixa etária de 20 a 49 anos a mais atingida. O diagnóstico clínico-epidemiológico foi realizado em 52% dos casos, a forma clínica mais prevalente foi a cutânea e o tratamento mais comum foi o antimonial, de primeira linha no Brasil. Visto que não havia estudos da doença no município, este trabalho pode contribuir para o entendimento epidemiológico da enfermidade na região e assim contribuir para a tomada de medidas mais assertivas para o controle e prevenção da mesma.
- 23 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (14)
Open AccessLeishmaniose Tegumentar Americana: uma análise epidemiológica do município de Teófilo Otoni-MG
Em gradual processo de urbanização, a Leishmaniose Tegumentar Americana (LTA) é uma antropozoonose preocupante em decorrência da sua gravidade e ameaça à saúde pública. O presente trabalho teve como objetivo avaliar a incidência de casos de LTA no período de 2014 a 2018 e traçar um perfil epidemiológico da enfermidade no município de Teófilo Otoni – MG a partir dos dados: sexo, faixa-etária, raça, forma de entrada no sistema, área de moradia e bairro, formas clínicas apresentadas, método diagnóstico e medicações utilizadas no tratamento. Foram notificados 75 casos no período, sendo a população parda, masculina e de faixa etária de 20 a 49 anos a mais atingida. O diagnóstico clínico-epidemiológico foi realizado em 52% dos casos, a forma clínica mais prevalente foi a cutânea e o tratamento mais comum foi o antimonial, de primeira linha no Brasil. Visto que não havia estudos da doença no município, este trabalho pode contribuir para o entendimento epidemiológico da enfermidade na região e assim contribuir para a tomada de medidas mais assertivas para o controle e prevenção da mesma.